Evaluation of the effect of fingolimod (FTY720) on macular perfusion by swept-source optical coherence tomography angiography in patients with multiple sclerosis.

CONCLUSION: Fingolimod use seems to remarkably increase VDs and VDd measurements in the early period of administration and decrease CMT over a longer period of administration in patients with RR-MS. PMID: 32657164 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32657164?dopt=Abstract

Source: Cutaneous and Ocular Toxicology - July 11, 2020 Category: Toxicology Authors: Karaküçük Y, Gümüş H, Eker S Tags: Cutan Ocul Toxicol Source Type: research